Oligonucleotide analogues, methods of synthesis and methods of use
CA 2402319 A1 · Owner: Archdeacon, Dorothy · Inventors: Archdeacon, Dorothy; Hondorp, Kyle; Buryakova, Alla
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to oligonucleotide analogues that include novel protein nucleic acid molecules (PNAs) particularly monomers, dimers, oligomers thereof and methods of making and using these oligonucleotide analogues. The PNAs of the present invention are characterized as including a variety of classes of molecules such as, for example, hydroxyproline peptide nucleic acids (HypNA) and serine peptide nucleic acids (SerNA). The invention includes monomers homodimers, heterodimers, homopolymers and heteropolymers of these and other oligonucleotide analogues. The present invention includes method of using these oligonucleotide analogues in the detection and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.